Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Melissa S. Baxter"'
Publikováno v:
Neurology International
Neurology International; Volume 7; Issue 1; Pages: 5809
Neurology International, Vol 7, Iss 1 (2015)
Neurology International; Volume 7; Issue 1; Pages: 5809
Neurology International, Vol 7, Iss 1 (2015)
The specific action of omega-3 fatty acid ethyl esters (OFA) in preventing cerebrovascular disease remains unknown, but research has demonstrated multiple possible mechanisms. In addition to altering lipid profiles, OFA may inhibit platelet aggregati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f5c4b0c223bf4968a2b19351a54c53
http://europepmc.org/articles/PMC4508542
http://europepmc.org/articles/PMC4508542
Diminished Response to Recombinant Factor Vila in a Patient with Idiopathic Thrombocytopenic Purpura
Publikováno v:
Annals of Pharmacotherapy. 40:2053-2058
Objective: To describe the hypotheses that may explain a diminished hemostatic response in a patient receiving multiple doses of recombinant coagulation factor Vila (rFVIIa) for off-label treatment of bleeding events. Case Summary: A 70-year-old fema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48f5318ffd59e75ed6911c6a8852385
https://doi.org/10.1345/aph.1h331
https://doi.org/10.1345/aph.1h331
Publikováno v:
Clinical Neurology and Neurosurgery. 115:2362-2364
Objective Intraventricular tissue plasminogen activator (alteplase) has been advocated for prevention of vasospasm in aneurysmal subarachnoid hemorrhage and treatment of traumatic or spontaneous intraventricular hemorrhage. External ventricular drain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1feed4fb83c5fde4f4dc07b6a241ca8b
https://doi.org/10.1016/j.clineuro.2013.08.018
https://doi.org/10.1016/j.clineuro.2013.08.018
Autor:
Adnan H. Siddiqui, Kenneth V. Snyder, Jorge L. Eller, Maxim Mokin, Travis M. Dumont, Sabareesh K. Natarajan, Melissa S. Baxter, L. Nelson Hopkins, Michael M. Wach, Elad I. Levy, Grant C. Sorkin
Publikováno v:
Journal of neurointerventional surgery. 6(5)
Objective Limited data exist regarding the use of antiplatelet response assays during neuroendovascular intervention. We report outcomes after carotid artery stenting (CAS) based on aspirin and P2Y12 assays. Methods We retrospectively identified pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::550cb8cd9ce7daeefe257e76c316d6cc
https://pubmed.ncbi.nlm.nih.gov/23794673
https://pubmed.ncbi.nlm.nih.gov/23794673
Publikováno v:
Neurology. 78:P03.004-P03.004
Objective: Does Lovaza have synergistic P2Y12-platelet inhibition in patients on Clopidogrel? Background The action of OFA in preventing cerebrovascular disease remains unknown. In addition to altering lipid profiles, OFA may have platelet aggregatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9a2fbff2e72265e9ab0fba269ae6853e
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p03.004
https://doi.org/10.1212/wnl.78.1_meetingabstracts.p03.004
Publikováno v:
Blood. 108:4033-4033
BACKGROUND: Recombinant factor VIIa (rFVIIa), NovoSeven®, is currently licensed in the United States for treatment of bleeding in hemophilia patients with acquired coagulation factor inhibitors. The off-label uses of this medication have expanded dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::614d99bba515f9a85845d5932b2ad55f
https://doi.org/10.1182/blood.v108.11.4033.4033
https://doi.org/10.1182/blood.v108.11.4033.4033